Drug Resistance to Inhibitors of the Human Double Minute-2 E3 Ligase Is Mediated by Point Mutations of P53, but Can Be Overcome With the P53 Targeting Agent RITA
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-12-0135
Full Text
Open PDFAbstract
Available in full text
Date
August 28, 2012
Authors
Publisher
American Association for Cancer Research (AACR)